Safety and Immunogenicity of DTP-IPV among Japanese adults

Safety and Immunogenicity of DTP-IPV among Japanese adults - Safety and Immunogenicity of DTP-IPV among Japanese adults

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029855

Enrollment

Registered

2017-11-08

Start date

2017-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diphtheria, Tetanus, Pertussis, Polio

Interventions

vaccination of DTP-IPV

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adult

Exclusion criteria

Exclusion criteria: acute febrile illness immunodeficiency allergy against vaccine components pregnancy

Design outcomes

Primary

Measure	Time frame
Diphtheria toxin antibody Tetanus toxin antibody anti-Pertussis antibody anti-poliovirus antibody	—

Secondary

Measure	Time frame
Adverse event	—

Countries

Japan

Contacts

Public ContactShinji Fukushima

Tokyo Medical University Hospital Travellers' Medical Center

fuku789@tokyo-med.ac.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026